Dr. Dolinar on Health Care - A Second Opinion
Why Did This Have to Happen...?
Devaluation of the dollar driving up the cost of healthcare
Pay for Performance
: Treating Physicians as Pets
Gasoline, Crack Cocaine and Health Care
Price facilitates the activities of the marketplace
New FDA Rules May Prompt Pig Latin Drug Names
Patients Prefer Injectable Over Inhaled Insulin
Pay-for-Performance: Physicians as Pets
P4P may hinder physician flexibility in treating patients.
Evidence-Based Medicine vs. Patients
Rosiglitazone viewed through a political prism
Drug price controls not advisable
Only one week to take advantage of Medicare Part D savings
Northwest Indiana Times
Remote Control Care: A dissenting view of evidence-based medicine
The DTC Double Standard
: Drug ads are singled out for flawed criticism
Evidence-Based Medicine Ainít Evidence Based
, September/October 2004
Defending products value.
The high cost of drugs in the U.S.
Free Market Economics:
Reps can impact the politics of healthcare delivery.
Prescription Pitches: Are Direct-to-Consumer Pharmaceutical Advertisements Confusing to Patients?
The New York Times, August 21, 2001
| Richard Dolinar, M.D. | Bilao LLC ©2010
Health Care Reform
Too Much Taxing
Health Care Policy
Cost of Healthcare
Medicare & Reform
Health Care Rationing
Pay 4 Performance
Biography - Dr Dolinar